Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. (Q48377599)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 October 2012

edit

Language	Label	Description	Also known as
English	Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.	scientific article published on 5 October 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

title

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

main subject

phase II clinical trial

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

imatinib

1 reference

based on heuristic

inferred from title

author

Khaled Ezzedine

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

Julien Seneschal

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

Adélaïde Doussau

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

Éric Hachulla

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

Carle Paul

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

author name string

S Prey

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

A-S Grandoulier

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

D Barcat

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

E Chatelus

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

E Diot

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

C Durant

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

J-D de Korwin-Krokowski

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

E Kostrzewa

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

T Quemeneur

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

T Schaeverbeke

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

A Solanilla

series ordinal

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

A Sparsa

series ordinal

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

S Bouchet

series ordinal

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

S Lepreux

series ordinal

19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

F-X Mahon

series ordinal

20

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

A Taïeb

series ordinal

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

G Chene

series ordinal

21

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

language of work or name

English

0 references

publication date

5 October 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

published in

British Journal of Dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

volume

167

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

page(s)

1138-1144

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

cites work

Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Regulation of PDGF and its receptors in fibrotic diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Is imatinib mesylate a promising drug in systemic sclerosis?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Molecular framework for response to imatinib mesylate in systemic sclerosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Imatinib for the treatment of refractory, diffuse systemic sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Imatinib treatment of generalized localized scleroderma (morphea)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11186.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2133.2012.11186.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

PubMed publication ID

23039171

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23039171

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23039171%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 March 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48377599&oldid=1694337402"